RE: NPV3 Apr 2019 17:08
Hi Mitch 984,
See my post of 27th March, where I tried to establish , from GLEN-related transactions, how NPV MIGHT translate into real world M Cap ie shareprice.
The examples I quoted came out between 1 and 3 % of NPV...and I haven't seen any counterargument so far.
That's because they're at the early, pre-committed finance stage, granted.
At the other end of the scale, I think we should recognise that no-one will give us NPV...or anything close .
Remember, NPV is an accountant's way of trying to level the playing field, so that we're comparing as far as possible like with like when considering an investment.
Which rational buyer would pay (using MM's conversion, I'll accept for the purpose of discussion, though I'm not clear about the underlying assumptions) £ 5-60 in order to get back the today EQUIVALENT ('cause that's what it is) of £5-60 over the next 20,30 or 40 years ? That's a long time to be exposed to product risk, country risk, technology risk, global pandemic or conflict etc etc.
So the read across, I would suggest is likely to be on a spectrum : a lot more than 1-3%, a lot less than 100%.
The nearest proxy for us that I've found appears to be Kropz (KRPZ), which is in the Congo, about the same stage as us, has a similar world -scale asset with convincing economics (potash) . And a S African owner, who will have (like the Chinese, maybe) a more confident take on Country Risk than most investors, making a 10% discount rate appropriatein his circumstances.
Kropz potash (19 Feb post) : "NPV" of $1,850M acquired for $ 40 M, implied worth MCap/NPV = 2.1%
The S African buyer was OK with a 10% discount rate in C-B, but his perception of country risk is relative. As, in fairness, would be a Chinese buyer, particularly if State or semiState...
Since Trahar appears to be a little more in 'marketing' mode, maybe someone should ask him for his views on the likely correlation NPV : M Cap ?
ATB